<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jacinto MP</submitter><funding>National Institute of General Medical Sciences</funding><funding>NIGMS NIH HHS</funding><pagination>1388-1393</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10124317</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>62(8)</volume><pubmed_abstract>Treatment of HeLa cells with the DNA damaging agent, bleomycin (BLM), results in the formation of a nonenzymatic 5-methylene-2-pyrrolone histone covalent modification on lysine residues (K&lt;sub>MP&lt;/sub>). K&lt;sub>MP&lt;/sub> is much more electrophilic than other &lt;i>N&lt;/i>-acyllysine covalent modifications and post-translational modifications, including &lt;i>N&lt;/i>-acetyllysine (K&lt;sub>Ac&lt;/sub>). Using histone peptides containing K&lt;sub>MP&lt;/sub>, we show that this modification inhibits the class I histone deacetylase, HDAC1, by reacting with a conserved cysteine (C261) located near the active site. HDAC1 is inhibited by histone peptides whose corresponding &lt;i>N&lt;/i>-acetylated sequences are known deacetylation substrates, but not one containing a scrambled sequence. The HDAC1 inhibitor, trichostatin A, </pubmed_abstract><journal>Biochemistry</journal><pubmed_title>Histone Deacetylase 1 Inhibition by Peptides Containing a DNA Damage-Induced, Nonenzymatic, Histone Covalent Modification.</pubmed_title><pmcid>PMC10124317</pmcid><funding_grant_id>GM-131736</funding_grant_id><funding_grant_id>R35 GM131736</funding_grant_id><pubmed_authors>Jacinto MP</pubmed_authors><pubmed_authors>Greenberg MM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Histone Deacetylase 1 Inhibition by Peptides Containing a DNA Damage-Induced, Nonenzymatic, Histone Covalent Modification.</name><description>Treatment of HeLa cells with the DNA damaging agent, bleomycin (BLM), results in the formation of a nonenzymatic 5-methylene-2-pyrrolone histone covalent modification on lysine residues (K&lt;sub>MP&lt;/sub>). K&lt;sub>MP&lt;/sub> is much more electrophilic than other &lt;i>N&lt;/i>-acyllysine covalent modifications and post-translational modifications, including &lt;i>N&lt;/i>-acetyllysine (K&lt;sub>Ac&lt;/sub>). Using histone peptides containing K&lt;sub>MP&lt;/sub>, we show that this modification inhibits the class I histone deacetylase, HDAC1, by reacting with a conserved cysteine (C261) located near the active site. HDAC1 is inhibited by histone peptides whose corresponding &lt;i>N&lt;/i>-acetylated sequences are known deacetylation substrates, but not one containing a scrambled sequence. The HDAC1 inhibitor, trichostatin A, </description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Apr</publication><modification>2026-04-29T14:14:15.613Z</modification><creation>2025-04-06T00:49:35.649Z</creation></dates><accession>S-EPMC10124317</accession><cross_references><pubmed>36972223</pubmed><doi>10.1021/acs.biochem.3c00007</doi></cross_references></HashMap>